Regeneron Pharmaceuticals, Inc.

Rafferty Asset Management, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

35,319

Value ($000)

27,262

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	27,262	0.1%	35,319	12/31/2025
2025 Q3	11/12/2025	26,130	0.1%	46,472	9/30/2025
2025 Q2	8/14/2025	27,630	0.1%	52,628	6/30/2025
2025 Q1	5/14/2025	28,351	0.1%	44,702	3/31/2025
2024 Q4	2/14/2025	33,913	0.1%	47,608	12/31/2024
2024 Q3	11/13/2024	37,528	0.1%	35,699	9/30/2024
2024 Q2	8/13/2024	43,320	0.2%	41,217	6/30/2024
2024 Q1	5/13/2024	32,024	0.1%	33,272	3/31/2024
2023 Q4	2/13/2024	30,016	0.1%	34,176	12/31/2023
2023 Q3	11/13/2023	26,380	0.2%	32,055	9/30/2023
2023 Q2	8/11/2023	22,019	0.1%	30,644	6/30/2023
2023 Q1	5/11/2023	21,095	0.1%	25,673	3/31/2023
2022 Q4	2/13/2023	18,785	0.2%	26,037	12/31/2022
2022 Q3	11/14/2022	17,078	0.2%	24,792	9/30/2022
2022 Q2	8/12/2022	12,015	0.1%	20,325	6/30/2022
2022 Q1	5/13/2022	14,822	0.1%	21,222	3/31/2022
2021 Q4	2/10/2022	11,422	0.1%	18,086	12/31/2021
2021 Q3	11/10/2021	8,835	0.1%	14,599	9/30/2021
2021 Q2	8/10/2021	7,783	0.0%	13,934	6/30/2021
2021 Q1	5/10/2021	7,866	0.1%	16,625	3/31/2021
2020 Q4	2/10/2021	5,391	0.1%	11,159	12/31/2020
2020 Q3	11/13/2020	5,968	0.1%	10,662	9/30/2020
2020 Q2	8/7/2020	5,584	0.1%	8,954	6/30/2020
2020 Q1	5/15/2020	4,014	0.2%	8,221	3/31/2020
2019 Q4	2/10/2020	7,460	0.1%	19,867	12/31/2019
2014 Q1	5/14/2014	403	0.1%	1,341	3/31/2014
2013 Q4	2/6/2014	265	0.1%	962	12/31/2013